MAPT and Alzheimer disease: The stimulation of the entorhinal cortex (EC) using deep brain stimulation (DBS) has been shown to markedly decrease the concentrations of amyloid-beta (Ab) and tau in the hippocampus of transgenic mouse models for Alzheimer’s disease, along with reducing total tau and phosphorylated tau levels in the cortical area [66].